Abstract: . . .  therapeutic cloning . However, research using adult stem cells is allowed – indeed it is considered a priority – and such research qualifies for support. So too does research on surplus (or ‘supernumerary’ embryos, as they are called: these are frozen embryos prepared for in vitro fertilisation, but no longer needed). Work on foetal stem cells derived from spontaneous or therapeutic abortion may also be funded.  . . .
. . .  source for new therapies. So far, they have principally been identified in and isolated from the brain, skin, and bone marrow, and recent research suggests that body fat may offer another possibility). WHAT ARE THE CURRENT RESEARCH NEEDS? Researchers have been working with embryonic stem cells for over 30 years, and further investigation is still required to fully understand the mechanisms that make stem cells differentiate into particular types of cells. The ultimate aim is to learn how to reprogramme adult stem cells. Then, when someone is . . .
. . .  inevitably lead to human reproductive - cloning – the appearance of artificially-created “copy” human beings. Today, the base line of the EU and US positions (the so-called "Bush compromise") is to exclude from funding any research that involves human reproductive and therapeutic cloning . However, research using adult stem cells is allowed – indeed it is considered a priority – and such research qualifies for support. So too does research on surplus (or ‘supernumerary’ embryos, as they are called: these are frozen embryos prepared for in vitro fertilisation, . . .
--1764,3,294,1858,8819